Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-01

Clinical Trial Update: Effect of Fixed Combination Citicoline Homotaurine and Pyrroloquinoline Quinone on Pattern-electroretinogram in Glaucoma [Phase 3]

View source ↗

Summary

Phase 3 trial completed evaluating a fixed combination of citicoline, homotaurine, and pyrroloquinoline quinone for neuroprotection in glaucoma, with pattern-el…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Citicoline (CDP-choline)
  • Homotaurine (homotaurine)
  • Pyrroloquinoline Quinone (pyrroloquinoline quinone)

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Glaucoma, Neuroprotection | Phase 3 | Status: COMPLETED